SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-036805
Filing Date
2022-03-23
Accepted
2022-03-23 08:30:53
Documents
15
Period of Report
2022-03-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2210202d1_8k.htm   iXBRL 8-K 36597
2 EXHIBIT 10.1 tm2210202d1_ex10-1.htm EX-10.1 97440
3 EXHIBIT 99.1 tm2210202d1_ex99-1.htm EX-99.1 14481
7 GRAPHIC tm2210202d1_ex99-1img01.jpg GRAPHIC 12384
  Complete submission text file 0001104659-22-036805.txt   375530

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA syn-20220322.xsd EX-101.SCH 3060
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20220322_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20220322_pre.xml EX-101.PRE 22614
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2210202d1_8k_htm.xml XML 3615
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 22761651
SIC: 2834 Pharmaceutical Preparations